We find Bromley et al.’s report of an increased incidence of autism spectrum disorders in the offspring of mothers taking antiepileptic drugs (AEDs) during pregnancy intriguing and suggest low vitamin D as a possible mechanism deserving further investigation. [1]
Several AEDs are known to bind to the pregnane X receptor (PXR) to increase the catabolism of vitamin D by up regulating the mitochondrial enzyme CYP24. AEDs, including VPA, are known to decrease 25-hydroxyvitamin D levels. [2] It has been reported that babies born to women taking AEDs during pregnancy had significantly lower 25-hydroxyvitamin D concentrations compared to healthy control newborns. [3] Vitamin D is a secosteroid hormone that has important extra-skeletal functions. Vitamin D deficiency, and in particular gestational deficiency, has been implicated in an expanding list of extra skeletal neuropsychiatric disorders including schizophrenia and autism. [4,5]
The vitamin D receptor (VDR) and 1-alpha-hydroxylase, the enzyme that converts the circulating form of vitamin D and (25-hydroxyvitamin D) the hormonal form of vitamin D, (1,25-dihydroxyvitamin D) have been found throughout the central nervous system. Furthermore, vitamin D regulates production of neurotrophins and growth factors that have an integral role in neuronal differentiation, growth and survival.
An ecological study of autism suggested that there was a significant increase in the prevalence of autism with increasing latitude, varying from 1.3/100,000 at 32 degrees to about 6.1/100,000 at 57 degrees. [5] It was also noted that children born in winter months, when vitamin D levels are lower, are at increased risk of developing autism. We suspect that children born to women taking AEDs during pregnancy are at increased risk for vitamin D insufficiency compared to the children whose mothers did not take AEDs.
The increasing incidence of vitamin D insufficiency is likely also associated with the increased risk of autism spectrum disorders as reported in this cohort, thus supporting the hypothesis that gestational vitamin D deficiency is autism's environmental trigger, one that allows the phenotypic expression of autism in genetically susceptible children. [5]
References
1. Bromley RL, Mawer G, Clayton-Smith J, Baker GA, On behalf of the Liverpool and Manchester Neurodevelopment G. Autism Spectrum Disorders Following in Utero Exposure to Antiepileptic Drugs. Neurology 2008;71:1923-1924.
2. Kulak CA, Borba VZ, Bilezikian JP, Silvado CE, Paola L, Boguszewski CL. Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs. Arq Neuropsiquiatr 2004;62:940-948.
3. Markestad T, Ulstein M, Strandjord RE, Aksnes L, Aarskog D. Anticonvulsant drug therapy in human pregnancy: effects on serum concentrations of vitamin D metabolites in maternal and cord blood. Am J Obstet Gynecol 1984;150:254-258.
4. Holick MF. Vitamin D deficiency. New England Journal of Medicine 2007;357:266-281.
5. Cannell JJ. Autism and vitamin D. Med Hypotheses 2008;70:750-759.
Disclosures: MLE, MRD, and VT have no relevant disclosures; WBG receives funding from the UV Foundation (McLean, VA); JJC is president of the non-profit educational organization, the Vitamin D Council.
Editor’s Note: The authors of the article were offered the opportunity to respond but declined.